These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 33321083)

  • 1. Visualizing Cancer.
    Krummel M; Hu K; de Vries EGE; Goetz JG; Passaro D; Subramaniam S; Misteli T; Skala M; Bravo-Cordero JJ; Sutcliffe JL
    Cancer Cell; 2020 Dec; 38(6):753-756. PubMed ID: 33321083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular imaging of the tumor microenvironment for precision medicine and theranostics.
    Penet MF; Krishnamachary B; Chen Z; Jin J; Bhujwalla ZM
    Adv Cancer Res; 2014; 124():235-56. PubMed ID: 25287691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Perspectives of Single-Cell RNA Sequencing.
    Kim N; Eum HH; Lee HO
    Biomolecules; 2021 Aug; 11(8):. PubMed ID: 34439827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. F-18 fluoromisonidazole for imaging tumor hypoxia: imaging the microenvironment for personalized cancer therapy.
    Rajendran JG; Krohn KA
    Semin Nucl Med; 2015 Mar; 45(2):151-62. PubMed ID: 25704387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How Imaging Biomarkers Can Inform Clinical Trials and Clinical Practice in the Era of Targeted Cancer Therapy.
    Farwell MD; Clark AS; Mankoff DA
    JAMA Oncol; 2015 Jul; 1(4):421-2. PubMed ID: 26181243
    [No Abstract]   [Full Text] [Related]  

  • 6. Real time dynamic imaging and current targeted therapies in the war on cancer: a new paradigm.
    Paulmurugan R; Oronsky B; Brouse CF; Reid T; Knox S; Scicinski J
    Theranostics; 2013; 3(6):437-47. PubMed ID: 23781290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular imaging of the tumor microenvironment.
    Zhou Z; Lu ZR
    Adv Drug Deliv Rev; 2017 Apr; 113():24-48. PubMed ID: 27497513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear Mechanopathology and Cancer Diagnosis.
    Uhler C; Shivashankar GV
    Trends Cancer; 2018 Apr; 4(4):320-331. PubMed ID: 29606315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noninvasive imaging in cancer immunotherapy: The way to precision medicine.
    Du Y; Qi Y; Jin Z; Tian J
    Cancer Lett; 2019 Dec; 466():13-22. PubMed ID: 31499119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noninvasive imaging of the PD-1:PD-L1 immune checkpoint: Embracing nuclear medicine for the benefit of personalized immunotherapy.
    Broos K; Lecocq Q; Raes G; Devoogdt N; Keyaerts M; Breckpot K
    Theranostics; 2018; 8(13):3559-3570. PubMed ID: 30026866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Editorial. Molecular image-guided cancer treatment: moving towards personalized medicine--Part I.
    Liu Z
    Curr Pharm Biotechnol; 2013; 14(7):643. PubMed ID: 24476455
    [No Abstract]   [Full Text] [Related]  

  • 12. [Bio-imaging and molecular targeted therapy of cancer].
    Imamura T; Oshima Y; Saitou T
    Nihon Rinsho; 2015 Aug; 73(8):1246-9. PubMed ID: 26281673
    [No Abstract]   [Full Text] [Related]  

  • 13. Cancer stem cell targeting: the next generation of cancer therapy and molecular imaging.
    Shigdar S; Lin J; Li Y; Yang CJ; Wei M; Zhus Y; Liu H; Duan W
    Ther Deliv; 2012 Feb; 3(2):227-44. PubMed ID: 22834199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer-focused molecular imaging.
    Shagam JY
    Radiol Technol; 2010; 82(1):59-80. PubMed ID: 20826600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of Companion Diagnostics.
    Mankoff DA; Edmonds CE; Farwell MD; Pryma DA
    Semin Nucl Med; 2016 Jan; 46(1):47-56. PubMed ID: 26687857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In Vitro and In Vivo Imaging of Fluorescent Aptamers.
    Théodorou I; Quang NN; Gombert K; Thézé B; Lelandais B; Ducongé F
    Methods Mol Biol; 2016; 1380():135-50. PubMed ID: 26552822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishing the Evidence Bar for Molecular Diagnostics in Personalised Cancer Care.
    Schneider D; Bianchini G; Horgan D; Michiels S; Witjes W; Hills R; Plun-Favreau J; Brand A; Lawler M;
    Public Health Genomics; 2015; 18(6):349-58. PubMed ID: 26571110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imaging preclinical tumour models: improving translational power.
    de Jong M; Essers J; van Weerden WM
    Nat Rev Cancer; 2014 Jul; 14(7):481-93. PubMed ID: 24943811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular Imaging of IGF-1R in Cancer.
    Sun Y; Sun X; Shen B
    Mol Imaging; 2017; 16():1536012117736648. PubMed ID: 29169312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imaging requirements for personalized medicine: the oncologists point of view.
    Kruse V; Belle SV; Cocquyt V
    Curr Pharm Des; 2014; 20(14):2234-49. PubMed ID: 24025098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.